Sign in

CIK 0001326732

  • Accelerated filer
Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
201622502
Phone
+1 626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
  1. 4 Open-market sale SR. VICE PRESIDENT & CSO sold 2,663 shares at $11.90 ($31,677)
  2. 4 Grant or award SR. VICE PRESIDENT & CFO acquired 19,458 shares (grant or award)
  3. 4 Open-market sale SVP, GENERAL COUNSEL sold 1,492 shares at $11.90 ($17,747)
  4. 4 Open-market sale PRESIDENT & CEO sold 6,758 shares at $11.90 ($80,387)
  5. 4 Exercise or conversion SR. VICE PRESIDENT & CSO acquired 5,322 shares (option exercise)
  6. 4 Open-market sale SR. VICE PRESIDENT & CSO sold 73,367 shares at $15.72 ($1,153,329)
  7. 4 Open-market sale PRESIDENT & CEO sold 114,377 shares at $15.71 ($1,796,863)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Director sold 2,215 shares at $9.22 ($20,422)
  11. 4 Grant or award Director acquired 13,686 shares (grant or award)
  12. 4 Planned sale Director sold 2,993 shares at $9.22 ($27,595)
  13. 4 Planned sale Director sold 3,173 shares at $9.22 ($29,255)
  14. 4 Planned sale Director sold 2,993 shares at $9.22 ($27,595)
  15. 4 Grant or award Director acquired 13,686 shares (grant or award)
  16. 4 Planned sale Director sold 2,993 shares at $9.22 ($27,595)
  17. 4 Open-market sale EVP, Chief Development Officer sold 4,616 shares at $11.03 ($50,914)
  18. 4 Open-market sale SR. VICE PRESIDENT & CFO sold 3,750 shares at $8.06 ($30,233)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 2 of 21 · 415 filings